Pharsight

VERTEX PHARMACEUTICALS INCORPORATED PATENTS FACING OPPOSITIONS

Top patents of VERTEX PHARMACEUTICALS INCORPORATED facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2464337B1 09 Jan, 2019 Pharmaceutical composition and administrations thereof NA 1
EP2914248B2 05 Sep, 2018 Pharmaceutical compositions for the treatment of cftr mediated diseases NA 1
EP3131582B1 23 May, 2018 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases NA 1